Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 168 citing Rossing: Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended.... (0.12 sec) 

Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 …


K ROSSING, KJ SCHJOEDT, BR JENSEN, F … - Kidney international, 2005 - nature.com
This double-masked randomized crossover trial included 52 (41 males)
hypertensive type 2 diabetic patients with microalbuminuria on ongoing
antihypertensive medication. At inclusion, previous antihypertensive ...
Cited by 129 - Related articles - BL Direct - All 3 versions

Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric …


M MacKinnon, S Shurraw, A Akbari, GA Knoll, … - American Journal of Kidney Diseases, 2006 - Elsevier
Blockade of the renin-angiotensin system with either an angiotensin-converting
enzyme (ACE) inhibitor or an angiotensin receptor blocker (ARB) was shown to
decrease urinary protein excretion and slow the progression of both ...
Cited by 121 - Related articles - All 3 versions

Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin …

- annals.org
R Kunz, C Friedrich, M Wolbers, JFE Mann - Annals of Internal Medicine, 2007 - Am Coll Physicians
This position paper concerns improving health care in the United States. Unlike
previous highly focused policy papers by the American College of Physicians,
this article takes a comprehensive approach to improving access, quality, ...
Cited by 115 - Related articles - BL Direct - All 6 versions

Renin inhibition: what are the therapeutic opportunities?

- asnjournals.org
NDL Fisher, NK Hollenberg - Journal of the American Society of Nephrology, 2005 - Am Soc Nephrol
Three years ago, we responded to an invitation from Expert Opinion in
Investigative Drugs to address the current status of renin inhibition (1). We
bemoaned that all development of renin inhibitors seemed to have come to an ...
Cited by 103 - Related articles - All 6 versions

Beneficial effects of adding spironolactone to recommended antihypertensive treatment in …


K Rossing, KJ Schjoedt, UM Smidt, F … - Diabetes Care, 2005 - Am Diabetes Assoc
RESULTS—During the addition of placebo, values were as follows: albuminuria
(geometric mean [range]) 1,566 [655–7,762] mg/24 h, ABP (mean ± SE) 138 ±
3/71 ± 1 mmHg, and GFR (mean ± SE) 74 ± 6 ml/min per 1.73 m 2 . During ...
Cited by 88 - Related articles - BL Direct - All 5 versions

Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin …

- ahajournals.org
TWR Doulton, FJ He, GA MacGregor - Hypertension, 2005 - Am Heart Assoc
Some evidence suggests that long-term angiotensin-converting enzyme (ACE)
inhibition may become less effective, thereby increasing angiotensin II levels,
which could be inhibited by the addition of an angiotensin receptor ...
Cited by 83 - Related articles - All 10 versions

Long-term dual blockade with candesartan and lisinopril in hypertensive patients with …

- diabetesjournals.org
NH Andersen, P Poulsen… - Diabetes Care, 2005 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—This was a prospective, randomized,
parallel-group, double-blind, double-dummy study with a 12-month follow-up. Drug
therapy was either lisinopril 40 mg once daily or dual-blockade treatment ...
Cited by 78 - Related articles - All 8 versions

Beneficial impact of spironolactone in diabetic nephropathy


KJ Schjoedt, K Rossing, TR Juhl, F Boomsma, … - Kidney international, 2005 - nature.com
Aldosterone has been suggested to play a role in the initiation and progression
of diabetic nephropathy. Currently recommended treatment with
angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor ...
Cited by 75 - Related articles - BL Direct - All 5 versions

Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a …

- physiology.org [PDF] 
JT Lane - American Journal of Physiology- Renal Physiology, 2004 - Am Physiological Soc
286:442-450, 2004. doi:10.1152/ajprenal.00247.2003 Am J Physiol Renal Physiol
James T. Lane ... You might find this additional information useful... ... 127
articles, 70 of which you can access free at: This article cites ...
Cited by 72 - Related articles - BL Direct - All 6 versions

Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy


KJ Schjoedt, K Rossing, TR Juhl, F Boomsma, … - Kidney international, 2006 - nature.com
Reduction of nephrotic range albuminuria is associated with markedly improved
renal and cardiovascular outcome in patients with diabetic nephropathy.
Aldosterone has been suggested to play a role in the progression of ...
Cited by 63 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google